#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant melanoma Peritoneal neoplasm Myeloproliferative neoplasm Neuropathic arthropathy Anti-HLA antibody test positive Fragile X syndrome Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Kawasaki's disease Paroxysmal nocturnal haemoglobinuria Hyperoxaluria Hypochondroplasia B precursor type acute leukaemia Subdural haematoma Chondrodystrophy Anti-myelin-associated glycoprotein antibodies positive More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Life with Disease Immunodeficiency congenital – Diagnostics Mucopolysaccharidosis III – Basic Information Soft tissue sarcoma – Life with Disease Toxic epidermal necrolysis – Life with Disease Cystic fibrosis – Trials in Disease Optic glioma – Diagnostics Pemphigus – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Cholangitis sclerosing – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bay 2927088 Filgrastim Nizaracianine Triflutate Sarilumab Metoclopramide [18F]DED Levetiracetam TRONTINEMAB Gad20-209-Fsp-A3 Keto-Leucine Calcium Efepoetin Alfa Methotrexate Cefoxitin Hhalpc Ds-2325A Dexmedetomidine Hydrochloride AMMONIUM (15N) CHLORIDE Enalapril Maleate Hydrocortisone Acetate Temozolomide More therapies…

    Learn about Your Condition

    Hypersomnia Hypotension Cardiac disorder Systemic infection Ovarian cancer recurrent Thrombolysis Synovitis Hypochondroplasia Neurofibromatosis Compulsive sexual behaviour Alveolar proteinosis Glomerulonephritis membranous Choroidal neovascularisation Sickle cell disease Tachypnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Spain

  • Study of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Ladarixin
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    Italy

  • A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Belgium Italy The Netherlands Norway

  • Study evaluating the effect of isotretinoin on sperm production in men with low sperm count

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Isotretinoin
    France

  • A study of belantamab mafodotin and mezigdomide in patients with relapsed multiple myeloma who have previously received CAR-T cell therapy or bispecific antibodies

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Mezigdomide
    • Belantamab Mafodotin
    France

  • A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Petosemtamab
    • Pembrolizumab
    Belgium France Italy The Netherlands Poland Spain
Previous Page
1 … 724 725 726 727 728 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!